We do not have a figure for medicines and medical devices specifically. As a nation, we have a goal that we should reach 2.4% of GDP spent on research. We are increasing the medical research budget; for instance, we are doubling the budget for research into dementia. As my right hon. Friend rightly points out, the public budget for research is only one part of it. There is huge private sector and charitable sector investment —for instance, from the Wellcome Trust. The Bill will allow research money—whether it comes from the public sector, private sector or third sector—to go further and get medicines and medical devices to NHS patients faster, as well as supporting our life sciences sector.
Medicines and Medical Devices Bill
Proceeding contribution from
Matt Hancock
(Conservative)
in the House of Commons on Monday, 2 March 2020.
It occurred during Debate on bills on Medicines and Medical Devices Bill.
Type
Proceeding contribution
Reference
672 c659 
Session
2019-21
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2024-08-22 11:56:35 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2020-03-02/20030241000049
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2020-03-02/20030241000049
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2020-03-02/20030241000049